nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD4—obesity	0.0734	0.238	CbGaD
Methotrimeprazine—DRD1—obesity	0.0622	0.201	CbGaD
Methotrimeprazine—Ethopropazine—Diethylpropion—obesity	0.0604	0.284	CrCrCtD
Methotrimeprazine—HTR2C—obesity	0.0532	0.172	CbGaD
Methotrimeprazine—DRD2—obesity	0.0438	0.142	CbGaD
Methotrimeprazine—CYP2E1—obesity	0.0422	0.137	CbGaD
Methotrimeprazine—ADRA1B—Phendimetrazine—obesity	0.0357	0.108	CbGbCtD
Methotrimeprazine—Ethopropazine—Benzphetamine—obesity	0.0353	0.166	CrCrCtD
Methotrimeprazine—Trimipramine—Benzphetamine—obesity	0.0345	0.162	CrCrCtD
Methotrimeprazine—HTR2A—obesity	0.0339	0.11	CbGaD
Methotrimeprazine—DRD1—Phenylpropanolamine—obesity	0.0322	0.0977	CbGbCtD
Methotrimeprazine—Promethazine—Benzphetamine—obesity	0.0292	0.137	CrCrCtD
Methotrimeprazine—Alimemazine—Benzphetamine—obesity	0.0287	0.135	CrCrCtD
Methotrimeprazine—ADRA1A—Phendimetrazine—obesity	0.0281	0.0855	CbGbCtD
Methotrimeprazine—ADRA2C—Methamphetamine—obesity	0.0269	0.0819	CbGbCtD
Methotrimeprazine—ADRA2B—Methamphetamine—obesity	0.0256	0.0776	CbGbCtD
Methotrimeprazine—Promazine—Benzphetamine—obesity	0.0247	0.116	CrCrCtD
Methotrimeprazine—ADRA2A—Benzphetamine—obesity	0.0222	0.0676	CbGbCtD
Methotrimeprazine—ADRA1A—Benzphetamine—obesity	0.0213	0.0648	CbGbCtD
Methotrimeprazine—ADRA2A—Phenylpropanolamine—obesity	0.0212	0.0644	CbGbCtD
Methotrimeprazine—ADRA1A—Phenylpropanolamine—obesity	0.0203	0.0618	CbGbCtD
Methotrimeprazine—ADRA2A—Methamphetamine—obesity	0.0178	0.054	CbGbCtD
Methotrimeprazine—CYP2E1—Bupropion—obesity	0.0132	0.0401	CbGbCtD
Methotrimeprazine—CYP2E1—Cimetidine—obesity	0.00969	0.0294	CbGbCtD
Methotrimeprazine—CYP1A2—Phentermine—obesity	0.00898	0.0273	CbGbCtD
Methotrimeprazine—CYP1A2—Phenylpropanolamine—obesity	0.00856	0.026	CbGbCtD
Methotrimeprazine—CYP1A2—Bupropion—obesity	0.00763	0.0232	CbGbCtD
Methotrimeprazine—CYP2D6—Phentermine—obesity	0.0074	0.0225	CbGbCtD
Methotrimeprazine—CYP2D6—Bupropion—obesity	0.00629	0.0191	CbGbCtD
Methotrimeprazine—CYP2D6—Methamphetamine—obesity	0.00591	0.018	CbGbCtD
Methotrimeprazine—Sudden death, cause unknown—Sibutramine—obesity	0.00563	0.133	CcSEcCtD
Methotrimeprazine—CYP1A2—Cimetidine—obesity	0.0056	0.017	CbGbCtD
Methotrimeprazine—CYP2D6—Cimetidine—obesity	0.00462	0.014	CbGbCtD
Methotrimeprazine—Liver injury—Phenylpropanolamine—obesity	0.00214	0.0505	CcSEcCtD
Methotrimeprazine—CHRM3—muscle of abdomen—obesity	0.00187	0.144	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Phenylpropanolamine—obesity	0.0018	0.0425	CcSEcCtD
Methotrimeprazine—Liver injury—Cimetidine—obesity	0.00169	0.04	CcSEcCtD
Methotrimeprazine—Sudden death—Sibutramine—obesity	0.00149	0.0352	CcSEcCtD
Methotrimeprazine—Urinary retention—Phenylpropanolamine—obesity	0.00124	0.0294	CcSEcCtD
Methotrimeprazine—Drowsiness—Phenylpropanolamine—obesity	0.00101	0.0238	CcSEcCtD
Methotrimeprazine—Urinary retention—Cimetidine—obesity	0.000984	0.0233	CcSEcCtD
Methotrimeprazine—HTR2A—sympathetic nervous system—obesity	0.000916	0.0706	CbGeAlD
Methotrimeprazine—HTR2A—vagus nerve—obesity	0.000887	0.0684	CbGeAlD
Methotrimeprazine—Drug interaction—Orlistat—obesity	0.000849	0.02	CcSEcCtD
Methotrimeprazine—Drowsiness—Diethylpropion—obesity	0.000838	0.0198	CcSEcCtD
Methotrimeprazine—Tachycardia—Methamphetamine—obesity	0.000835	0.0197	CcSEcCtD
Methotrimeprazine—Tachycardia—Benzphetamine—obesity	0.000805	0.019	CcSEcCtD
Methotrimeprazine—Drowsiness—Cimetidine—obesity	0.000798	0.0188	CcSEcCtD
Methotrimeprazine—Liver injury—Bupropion—obesity	0.000789	0.0186	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Diethylpropion—obesity	0.000782	0.0185	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Cimetidine—obesity	0.000745	0.0176	CcSEcCtD
Methotrimeprazine—Tachycardia—Phendimetrazine—obesity	0.000734	0.0173	CcSEcCtD
Methotrimeprazine—Constipation—Methamphetamine—obesity	0.000732	0.0173	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Bupropion—obesity	0.000664	0.0157	CcSEcCtD
Methotrimeprazine—Constipation—Phendimetrazine—obesity	0.000643	0.0152	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methamphetamine—obesity	0.00063	0.0149	CcSEcCtD
Methotrimeprazine—Photosensitivity—Sibutramine—obesity	0.00063	0.0149	CcSEcCtD
Methotrimeprazine—Tachycardia—Phenylpropanolamine—obesity	0.000627	0.0148	CcSEcCtD
Methotrimeprazine—HTR2A—autonomic nervous system—obesity	0.000616	0.0474	CbGeAlD
Methotrimeprazine—Hypersensitivity—Benzphetamine—obesity	0.000608	0.0144	CcSEcCtD
Methotrimeprazine—Tachycardia—Phentermine—obesity	0.0006	0.0142	CcSEcCtD
Methotrimeprazine—Somnolence—Phenylpropanolamine—obesity	0.000571	0.0135	CcSEcCtD
Methotrimeprazine—Constipation—Phenylpropanolamine—obesity	0.000549	0.013	CcSEcCtD
Methotrimeprazine—Photosensitivity—Bupropion—obesity	0.000549	0.013	CcSEcCtD
Methotrimeprazine—Urinary retention—Sibutramine—obesity	0.000526	0.0124	CcSEcCtD
Methotrimeprazine—Constipation—Phentermine—obesity	0.000526	0.0124	CcSEcCtD
Methotrimeprazine—Tachycardia—Diethylpropion—obesity	0.000522	0.0123	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Sibutramine—obesity	0.000505	0.0119	CcSEcCtD
Methotrimeprazine—Tachycardia—Cimetidine—obesity	0.000497	0.0117	CcSEcCtD
Methotrimeprazine—Somnolence—Diethylpropion—obesity	0.000475	0.0112	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Phenylpropanolamine—obesity	0.000473	0.0112	CcSEcCtD
Methotrimeprazine—Urinary retention—Bupropion—obesity	0.000459	0.0108	CcSEcCtD
Methotrimeprazine—Constipation—Diethylpropion—obesity	0.000457	0.0108	CcSEcCtD
Methotrimeprazine—Drug interaction—Topiramate—obesity	0.000456	0.0108	CcSEcCtD
Methotrimeprazine—Somnolence—Cimetidine—obesity	0.000452	0.0107	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Bupropion—obesity	0.00044	0.0104	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Sibutramine—obesity	0.000436	0.0103	CcSEcCtD
Methotrimeprazine—Constipation—Cimetidine—obesity	0.000435	0.0103	CcSEcCtD
Methotrimeprazine—Weight increased—Sibutramine—obesity	0.000435	0.0103	CcSEcCtD
Methotrimeprazine—ADRA1A—hindbrain—obesity	0.000401	0.0309	CbGeAlD
Methotrimeprazine—DRD2—hindbrain—obesity	0.000393	0.0303	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Bupropion—obesity	0.00038	0.00899	CcSEcCtD
Methotrimeprazine—Weight increased—Bupropion—obesity	0.000379	0.00896	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Cimetidine—obesity	0.000375	0.00886	CcSEcCtD
Methotrimeprazine—Jaundice—Bupropion—obesity	0.000362	0.00856	CcSEcCtD
Methotrimeprazine—Urinary retention—Topiramate—obesity	0.000292	0.0069	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Topiramate—obesity	0.000281	0.00663	CcSEcCtD
Methotrimeprazine—DRD5—endocrine gland—obesity	0.000279	0.0215	CbGeAlD
Methotrimeprazine—Tachycardia—Sibutramine—obesity	0.000265	0.00627	CcSEcCtD
Methotrimeprazine—HTR2A—hindbrain—obesity	0.000259	0.02	CbGeAlD
Methotrimeprazine—CHRM2—cardiovascular system—obesity	0.000251	0.0193	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Topiramate—obesity	0.000242	0.00573	CcSEcCtD
Methotrimeprazine—Somnolence—Sibutramine—obesity	0.000242	0.00571	CcSEcCtD
Methotrimeprazine—Weight increased—Topiramate—obesity	0.000242	0.00571	CcSEcCtD
Methotrimeprazine—DRD2—respiratory system—obesity	0.00024	0.0185	CbGeAlD
Methotrimeprazine—CYP2D6—hindbrain—obesity	0.000236	0.0182	CbGeAlD
Methotrimeprazine—Constipation—Sibutramine—obesity	0.000232	0.00549	CcSEcCtD
Methotrimeprazine—Tachycardia—Bupropion—obesity	0.000231	0.00546	CcSEcCtD
Methotrimeprazine—CHRM1—cardiovascular system—obesity	0.000228	0.0176	CbGeAlD
Methotrimeprazine—ADRA1D—endocrine gland—obesity	0.000224	0.0173	CbGeAlD
Methotrimeprazine—Agranulocytosis—Topiramate—obesity	0.000221	0.00522	CcSEcCtD
Methotrimeprazine—Somnolence—Bupropion—obesity	0.000211	0.00498	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Orlistat—obesity	0.000207	0.00489	CcSEcCtD
Methotrimeprazine—Constipation—Bupropion—obesity	0.000203	0.00479	CcSEcCtD
Methotrimeprazine—CYP1A2—respiratory system—obesity	0.000203	0.0156	CbGeAlD
Methotrimeprazine—Hypersensitivity—Sibutramine—obesity	0.0002	0.00473	CcSEcCtD
Methotrimeprazine—ADRA2A—islet of Langerhans—obesity	0.000197	0.0152	CbGeAlD
Methotrimeprazine—ADRA2C—adrenal cortex—obesity	0.000196	0.0151	CbGeAlD
Methotrimeprazine—HRH1—respiratory system—obesity	0.00019	0.0146	CbGeAlD
Methotrimeprazine—ADRA1A—cardiovascular system—obesity	0.000188	0.0145	CbGeAlD
Methotrimeprazine—CYP2E1—respiratory system—obesity	0.000182	0.014	CbGeAlD
Methotrimeprazine—CHRM3—adipose tissue—obesity	0.00018	0.0139	CbGeAlD
Methotrimeprazine—Hypersensitivity—Bupropion—obesity	0.000175	0.00412	CcSEcCtD
Methotrimeprazine—CHRM2—endocrine gland—obesity	0.000172	0.0133	CbGeAlD
Methotrimeprazine—CHRM3—digestive system—obesity	0.00017	0.0131	CbGeAlD
Methotrimeprazine—ADRA1A—adipose tissue—obesity	0.000165	0.0128	CbGeAlD
Methotrimeprazine—DRD2—pituitary gland—obesity	0.000163	0.0126	CbGeAlD
Methotrimeprazine—HTR2A—respiratory system—obesity	0.000158	0.0122	CbGeAlD
Methotrimeprazine—ADRA2C—pituitary gland—obesity	0.000158	0.0122	CbGeAlD
Methotrimeprazine—ADRA2C—adipose tissue—obesity	0.000158	0.0122	CbGeAlD
Methotrimeprazine—CHRM1—endocrine gland—obesity	0.000157	0.0121	CbGeAlD
Methotrimeprazine—ADRA1A—adrenal gland—obesity	0.000148	0.0114	CbGeAlD
Methotrimeprazine—Tachycardia—Topiramate—obesity	0.000147	0.00348	CcSEcCtD
Methotrimeprazine—ADRA2C—adrenal gland—obesity	0.000141	0.0109	CbGeAlD
Methotrimeprazine—CHRM3—endocrine gland—obesity	0.00014	0.0108	CbGeAlD
Methotrimeprazine—CYP2E1—cardiovascular system—obesity	0.00014	0.0108	CbGeAlD
Methotrimeprazine—Somnolence—Topiramate—obesity	0.000134	0.00317	CcSEcCtD
Methotrimeprazine—Constipation—Topiramate—obesity	0.000129	0.00305	CcSEcCtD
Methotrimeprazine—CYP1A2—digestive system—obesity	0.000129	0.00993	CbGeAlD
Methotrimeprazine—ADRA1A—endocrine gland—obesity	0.000129	0.00992	CbGeAlD
Methotrimeprazine—HRH1—adipose tissue—obesity	0.000128	0.00987	CbGeAlD
Methotrimeprazine—ADRA2A—pituitary gland—obesity	0.000126	0.00974	CbGeAlD
Methotrimeprazine—DRD2—endocrine gland—obesity	0.000126	0.00972	CbGeAlD
Methotrimeprazine—ADRA2A—adipose tissue—obesity	0.000126	0.0097	CbGeAlD
Methotrimeprazine—HTR2A—cardiovascular system—obesity	0.000121	0.00935	CbGeAlD
Methotrimeprazine—HRH1—digestive system—obesity	0.000121	0.00929	CbGeAlD
Methotrimeprazine—ADRA1A—liver—obesity	0.000116	0.00894	CbGeAlD
Methotrimeprazine—CYP2E1—digestive system—obesity	0.000116	0.00893	CbGeAlD
Methotrimeprazine—HRH1—adrenal gland—obesity	0.000115	0.00885	CbGeAlD
Methotrimeprazine—ADRA2A—adrenal gland—obesity	0.000113	0.0087	CbGeAlD
Methotrimeprazine—Hypersensitivity—Topiramate—obesity	0.000111	0.00263	CcSEcCtD
Methotrimeprazine—ADRA2C—liver—obesity	0.000111	0.00852	CbGeAlD
Methotrimeprazine—CYP2E1—adrenal gland—obesity	0.00011	0.00851	CbGeAlD
Methotrimeprazine—HTR2A—pituitary gland—obesity	0.000107	0.00828	CbGeAlD
Methotrimeprazine—CYP1A2—endocrine gland—obesity	0.000106	0.0082	CbGeAlD
Methotrimeprazine—HTR2A—digestive system—obesity	0.000101	0.00776	CbGeAlD
Methotrimeprazine—HRH1—endocrine gland—obesity	9.96e-05	0.00768	CbGeAlD
Methotrimeprazine—ADRA2A—endocrine gland—obesity	9.79e-05	0.00754	CbGeAlD
Methotrimeprazine—HTR2A—adrenal gland—obesity	9.6e-05	0.00739	CbGeAlD
Methotrimeprazine—CYP1A2—liver—obesity	9.6e-05	0.00739	CbGeAlD
Methotrimeprazine—CYP2E1—endocrine gland—obesity	9.57e-05	0.00738	CbGeAlD
Methotrimeprazine—CYP2D6—digestive system—obesity	9.17e-05	0.00707	CbGeAlD
Methotrimeprazine—Acetophenazine—DRD1—obesity	9.1e-05	0.0325	CrCbGaD
Methotrimeprazine—CYP2E1—liver—obesity	8.63e-05	0.00665	CbGeAlD
Methotrimeprazine—HTR2A—endocrine gland—obesity	8.32e-05	0.00641	CbGeAlD
Methotrimeprazine—Propericiazine—DRD1—obesity	8.04e-05	0.0287	CrCbGaD
Methotrimeprazine—CYP2D6—endocrine gland—obesity	7.58e-05	0.00584	CbGeAlD
Methotrimeprazine—HTR2A—liver—obesity	7.5e-05	0.00578	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2C—obesity	6.88e-05	0.0246	CrCbGaD
Methotrimeprazine—CYP2D6—liver—obesity	6.83e-05	0.00527	CbGeAlD
Methotrimeprazine—Acetophenazine—DRD2—obesity	6.42e-05	0.0229	CrCbGaD
Methotrimeprazine—Acepromazine—SLC22A1—obesity	6.32e-05	0.0226	CrCbGaD
Methotrimeprazine—Ethopropazine—BCHE—obesity	6.19e-05	0.0221	CrCbGaD
Methotrimeprazine—Thioproperazine—SLC22A1—obesity	6.18e-05	0.0221	CrCbGaD
Methotrimeprazine—Pipotiazine—SLC22A1—obesity	6.08e-05	0.0217	CrCbGaD
Methotrimeprazine—Triflupromazine—DRD1—obesity	5.58e-05	0.02	CrCbGaD
Methotrimeprazine—Acepromazine—DRD1—obesity	5.17e-05	0.0185	CrCbGaD
Methotrimeprazine—Triflupromazine—BCHE—obesity	5.07e-05	0.0181	CrCbGaD
Methotrimeprazine—Thioproperazine—DRD1—obesity	5.05e-05	0.0181	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD1—obesity	4.97e-05	0.0178	CrCbGaD
Methotrimeprazine—Propiomazine—DRD4—obesity	4.88e-05	0.0174	CrCbGaD
Methotrimeprazine—Cyamemazine—HTR2A—obesity	4.38e-05	0.0157	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD1—obesity	4.29e-05	0.0153	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2C—obesity	4.19e-05	0.015	CrCbGaD
Methotrimeprazine—Propiomazine—DRD1—obesity	4.13e-05	0.0148	CrCbGaD
Methotrimeprazine—Prochlorperazine—HTR2C—obesity	4.06e-05	0.0145	CrCbGaD
Methotrimeprazine—Triflupromazine—DRD2—obesity	3.94e-05	0.0141	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD1—obesity	3.91e-05	0.014	CrCbGaD
Methotrimeprazine—Thioridazine—DRD1—obesity	3.7e-05	0.0132	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2C—obesity	3.67e-05	0.0131	CrCbGaD
Methotrimeprazine—Acepromazine—DRD2—obesity	3.64e-05	0.013	CrCbGaD
Methotrimeprazine—Promazine—DRD4—obesity	3.62e-05	0.0129	CrCbGaD
Methotrimeprazine—Thioproperazine—DRD2—obesity	3.56e-05	0.0127	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2C—obesity	3.53e-05	0.0126	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD2—obesity	3.5e-05	0.0125	CrCbGaD
Methotrimeprazine—Mesoridazine—DRD2—obesity	3.46e-05	0.0124	CrCbGaD
Methotrimeprazine—Perphenazine—DRD1—obesity	3.39e-05	0.0121	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2C—obesity	3.36e-05	0.012	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD2—obesity	3.35e-05	0.012	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2C—obesity	3.34e-05	0.012	CrCbGaD
Methotrimeprazine—Chlorpromazine—SLC22A1—obesity	3.29e-05	0.0118	CrCbGaD
Methotrimeprazine—Imipramine—SLC22A1—obesity	3.28e-05	0.0117	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD4—obesity	3.18e-05	0.0114	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2C—obesity	3.16e-05	0.0113	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2C—obesity	3.09e-05	0.0111	CrCbGaD
Methotrimeprazine—Promazine—DRD1—obesity	3.06e-05	0.0109	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD2—obesity	3.03e-05	0.0108	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2C—obesity	2.94e-05	0.0105	CrCbGaD
Methotrimeprazine—Fluphenazine—CYP2E1—obesity	2.91e-05	0.0104	CrCbGaD
Methotrimeprazine—Propiomazine—DRD2—obesity	2.91e-05	0.0104	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2C—obesity	2.9e-05	0.0104	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—obesity	2.81e-05	0.0101	CrCbGaD
Methotrimeprazine—Clomipramine—SLC6A4—obesity	2.78e-05	0.00995	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD2—obesity	2.76e-05	0.00985	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—obesity	2.75e-05	0.00983	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—obesity	2.71e-05	0.00968	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD1—obesity	2.69e-05	0.00963	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—obesity	2.67e-05	0.00955	CrCbGaD
Methotrimeprazine—Promazine—HTR2C—obesity	2.62e-05	0.00936	CrCbGaD
Methotrimeprazine—Thioridazine—DRD2—obesity	2.61e-05	0.00932	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A4—obesity	2.56e-05	0.00916	CrCbGaD
Methotrimeprazine—Trimipramine—DRD2—obesity	2.55e-05	0.00911	CrCbGaD
Methotrimeprazine—Thioridazine—CYP2E1—obesity	2.51e-05	0.00897	CrCbGaD
Methotrimeprazine—Promethazine—DRD2—obesity	2.45e-05	0.00877	CrCbGaD
Methotrimeprazine—Chlorpromazine—BCHE—obesity	2.45e-05	0.00874	CrCbGaD
Methotrimeprazine—Trifluoperazine—DRD2—obesity	2.42e-05	0.00865	CrCbGaD
Methotrimeprazine—Perphenazine—DRD2—obesity	2.39e-05	0.00856	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—obesity	2.34e-05	0.00836	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2C—obesity	2.3e-05	0.00824	CrCbGaD
Methotrimeprazine—Imipramine—HTR2C—obesity	2.29e-05	0.0082	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—obesity	2.25e-05	0.00804	CrCbGaD
Methotrimeprazine—Promazine—DRD2—obesity	2.16e-05	0.00771	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—obesity	2.14e-05	0.00765	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—obesity	2.13e-05	0.00761	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—obesity	2.01e-05	0.0072	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—obesity	1.97e-05	0.00704	CrCbGaD
Methotrimeprazine—Acepromazine—ALB—obesity	1.93e-05	0.00689	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A4—obesity	1.9e-05	0.00679	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD2—obesity	1.9e-05	0.00679	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—obesity	1.89e-05	0.00678	CrCbGaD
Methotrimeprazine—Imipramine—DRD2—obesity	1.89e-05	0.00675	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—obesity	1.88e-05	0.00673	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—obesity	1.87e-05	0.00669	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—obesity	1.85e-05	0.00662	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—obesity	1.85e-05	0.00661	CrCbGaD
Methotrimeprazine—Chlorpromazine—CYP2E1—obesity	1.83e-05	0.00653	CrCbGaD
Methotrimeprazine—Imipramine—CYP2E1—obesity	1.82e-05	0.0065	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—obesity	1.67e-05	0.00596	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—obesity	1.47e-05	0.00525	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—obesity	1.46e-05	0.00523	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—obesity	1.46e-05	0.00522	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—obesity	1e-05	0.00359	CrCbGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3R1—obesity	7.09e-07	7.77e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—obesity	7.09e-07	7.77e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MYC—obesity	7.09e-07	7.77e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—RHOA—obesity	7.08e-07	7.75e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—obesity	7.07e-07	7.75e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—obesity	7.06e-07	7.73e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3R1—obesity	7.02e-07	7.69e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—obesity	7.02e-07	7.69e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—obesity	7e-07	7.67e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3R1—obesity	7e-07	7.67e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MYC—obesity	6.99e-07	7.66e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—obesity	6.98e-07	7.64e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—obesity	6.95e-07	7.61e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—PIK3CA—obesity	6.92e-07	7.59e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AGT—obesity	6.91e-07	7.57e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CD—obesity	6.89e-07	7.55e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—obesity	6.88e-07	7.54e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—STAT3—obesity	6.87e-07	7.52e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—obesity	6.87e-07	7.52e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LPL—obesity	6.84e-07	7.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	6.83e-07	7.48e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—obesity	6.82e-07	7.47e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—PIK3CA—obesity	6.81e-07	7.46e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—PIK3CA—obesity	6.8e-07	7.45e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—STAT3—obesity	6.78e-07	7.42e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—STAT3—obesity	6.78e-07	7.42e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—PIK3CA—obesity	6.78e-07	7.42e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—obesity	6.77e-07	7.42e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—obesity	6.76e-07	7.4e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—obesity	6.76e-07	7.4e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—PIK3CA—obesity	6.76e-07	7.4e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CB—obesity	6.71e-07	7.35e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MTOR—obesity	6.71e-07	7.35e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CAV1—obesity	6.71e-07	7.35e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MYC—obesity	6.7e-07	7.34e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK8—obesity	6.69e-07	7.33e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOA1—obesity	6.69e-07	7.33e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—PIK3CA—obesity	6.69e-07	7.33e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—obesity	6.68e-07	7.32e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GPX1—obesity	6.67e-07	7.31e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—obesity	6.67e-07	7.31e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	6.67e-07	7.31e-06	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—obesity	6.66e-07	7.3e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—obesity	6.65e-07	7.29e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TYK2—obesity	6.63e-07	7.26e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—obesity	6.61e-07	7.24e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MTOR—obesity	6.6e-07	7.23e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CB—obesity	6.6e-07	7.23e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CB—obesity	6.6e-07	7.23e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MTOR—obesity	6.59e-07	7.22e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CB—obesity	6.59e-07	7.22e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—RHOA—obesity	6.58e-07	7.2e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CB—obesity	6.57e-07	7.19e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MTOR—obesity	6.57e-07	7.19e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CB—obesity	6.55e-07	7.17e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MTOR—obesity	6.55e-07	7.17e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—obesity	6.54e-07	7.16e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3R1—obesity	6.51e-07	7.13e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—obesity	6.51e-07	7.13e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CD36—obesity	6.5e-07	7.12e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MTOR—obesity	6.48e-07	7.1e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CB—obesity	6.48e-07	7.1e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MTOR—obesity	6.47e-07	7.08e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CB—obesity	6.47e-07	7.08e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—obesity	6.43e-07	7.04e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK8—obesity	6.43e-07	7.04e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—obesity	6.41e-07	7.02e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MYC—obesity	6.38e-07	6.99e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—obesity	6.37e-07	6.98e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—obesity	6.33e-07	6.93e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MYC—obesity	6.3e-07	6.9e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MYC—obesity	6.3e-07	6.9e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—obesity	6.28e-07	6.88e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—obesity	6.28e-07	6.88e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK8—obesity	6.25e-07	6.85e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—obesity	6.23e-07	6.83e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—obesity	6.23e-07	6.82e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	6.2e-07	6.79e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—obesity	6.16e-07	6.75e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK8—obesity	6.15e-07	6.74e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—obesity	6.14e-07	6.72e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—obesity	6.13e-07	6.72e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—obesity	6.13e-07	6.71e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—obesity	6.12e-07	6.7e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—obesity	6.12e-07	6.7e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CG—obesity	6.11e-07	6.69e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—obesity	6.1e-07	6.68e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—obesity	6.08e-07	6.66e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARA—obesity	6.04e-07	6.62e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—obesity	6.03e-07	6.61e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—obesity	6.02e-07	6.6e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PIK3CA—obesity	6.02e-07	6.59e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—obesity	6.02e-07	6.59e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CB—obesity	6.01e-07	6.58e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MTOR—obesity	6.01e-07	6.58e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—obesity	6e-07	6.57e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—obesity	6e-07	6.57e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—obesity	5.98e-07	6.55e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PIK3CA—obesity	5.94e-07	6.5e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—obesity	5.92e-07	6.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—obesity	5.91e-07	6.47e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—obesity	5.9e-07	6.46e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—obesity	5.88e-07	6.44e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AGT—obesity	5.85e-07	6.41e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—obesity	5.83e-07	6.39e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—obesity	5.82e-07	6.37e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—INS—obesity	5.78e-07	6.34e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—obesity	5.74e-07	6.29e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—obesity	5.73e-07	6.28e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—obesity	5.73e-07	6.27e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—obesity	5.72e-07	6.26e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—obesity	5.71e-07	6.25e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—obesity	5.69e-07	6.23e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—obesity	5.69e-07	6.23e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—obesity	5.69e-07	6.23e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAV1—obesity	5.68e-07	6.22e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK8—obesity	5.67e-07	6.21e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—obesity	5.67e-07	6.21e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOA1—obesity	5.67e-07	6.21e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—obesity	5.66e-07	6.2e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—obesity	5.63e-07	6.17e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—obesity	5.62e-07	6.16e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—obesity	5.62e-07	6.16e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK8—obesity	5.58e-07	6.11e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—obesity	5.58e-07	6.11e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK8—obesity	5.57e-07	6.1e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—obesity	5.57e-07	6.1e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—obesity	5.55e-07	6.08e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK8—obesity	5.55e-07	6.08e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—obesity	5.54e-07	6.07e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK8—obesity	5.53e-07	6.06e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—obesity	5.52e-07	6.05e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—obesity	5.49e-07	6.01e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK8—obesity	5.48e-07	6e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—obesity	5.47e-07	5.99e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK8—obesity	5.47e-07	5.99e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—obesity	5.46e-07	5.98e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—obesity	5.45e-07	5.97e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—obesity	5.45e-07	5.97e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.43e-07	5.95e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—obesity	5.42e-07	5.94e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—obesity	5.39e-07	5.91e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CD—obesity	5.37e-07	5.88e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—obesity	5.35e-07	5.86e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—obesity	5.35e-07	5.86e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—obesity	5.33e-07	5.84e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—obesity	5.31e-07	5.82e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—obesity	5.3e-07	5.81e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—obesity	5.3e-07	5.8e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—obesity	5.26e-07	5.76e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—obesity	5.23e-07	5.73e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—obesity	5.22e-07	5.72e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—obesity	5.21e-07	5.71e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—obesity	5.19e-07	5.68e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CG—obesity	5.18e-07	5.67e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—obesity	5.1e-07	5.59e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—obesity	5.09e-07	5.58e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK8—obesity	5.08e-07	5.56e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—obesity	5.08e-07	5.56e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3R1—obesity	5.07e-07	5.56e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—obesity	5.07e-07	5.56e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—obesity	5.06e-07	5.55e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—obesity	5.06e-07	5.54e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—obesity	5.03e-07	5.52e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—obesity	5.01e-07	5.49e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—obesity	5e-07	5.47e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—obesity	5e-07	5.47e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—obesity	4.93e-07	5.4e-06	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—obesity	4.92e-07	5.39e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—INS—obesity	4.9e-07	5.37e-06	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—obesity	4.85e-07	5.31e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—obesity	4.83e-07	5.29e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—obesity	4.82e-07	5.28e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—obesity	4.81e-07	5.27e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—obesity	4.8e-07	5.26e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—obesity	4.77e-07	5.23e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—obesity	4.74e-07	5.19e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—obesity	4.73e-07	5.19e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—obesity	4.73e-07	5.19e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—obesity	4.73e-07	5.18e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—obesity	4.73e-07	5.18e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—obesity	4.72e-07	5.17e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—obesity	4.72e-07	5.17e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—obesity	4.7e-07	5.15e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—obesity	4.7e-07	5.15e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—obesity	4.69e-07	5.14e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CB—obesity	4.68e-07	5.13e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—obesity	4.66e-07	5.1e-06	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—obesity	4.64e-07	5.09e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—obesity	4.64e-07	5.09e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—obesity	4.64e-07	5.09e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—obesity	4.64e-07	5.09e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—obesity	4.64e-07	5.08e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—obesity	4.64e-07	5.08e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—obesity	4.63e-07	5.07e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CD—obesity	4.55e-07	4.98e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—obesity	4.51e-07	4.94e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—obesity	4.49e-07	4.92e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—obesity	4.44e-07	4.86e-06	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—obesity	4.43e-07	4.85e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—obesity	4.4e-07	4.83e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—obesity	4.38e-07	4.8e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—obesity	4.37e-07	4.78e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—obesity	4.37e-07	4.78e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—obesity	4.31e-07	4.73e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—obesity	4.3e-07	4.71e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—obesity	4.3e-07	4.71e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3R1—obesity	4.3e-07	4.71e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—obesity	4.27e-07	4.68e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—obesity	4.1e-07	4.5e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—obesity	4.09e-07	4.48e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—obesity	4.03e-07	4.41e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—obesity	4.02e-07	4.41e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—obesity	4.02e-07	4.4e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—obesity	4e-07	4.39e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—obesity	3.99e-07	4.37e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—obesity	3.99e-07	4.37e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CB—obesity	3.97e-07	4.34e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—obesity	3.95e-07	4.33e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—obesity	3.94e-07	4.32e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—obesity	3.94e-07	4.32e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—obesity	3.93e-07	4.3e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—obesity	3.93e-07	4.3e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—obesity	3.9e-07	4.27e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—obesity	3.79e-07	4.15e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—obesity	3.68e-07	4.03e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—obesity	3.66e-07	4.01e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—obesity	3.62e-07	3.97e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—obesity	3.62e-07	3.97e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—obesity	3.58e-07	3.92e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—obesity	3.56e-07	3.9e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—obesity	3.56e-07	3.9e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—obesity	3.55e-07	3.88e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—obesity	3.53e-07	3.87e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—obesity	3.5e-07	3.83e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—obesity	3.49e-07	3.82e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—obesity	3.34e-07	3.66e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—obesity	3.29e-07	3.6e-06	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—obesity	3.29e-07	3.6e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—obesity	3.28e-07	3.59e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—obesity	3.27e-07	3.58e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—obesity	3.26e-07	3.57e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—obesity	3.24e-07	3.55e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—obesity	3.23e-07	3.54e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—obesity	3.22e-07	3.53e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—obesity	2.99e-07	3.28e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—obesity	2.85e-07	3.13e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—obesity	2.42e-07	2.65e-06	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—obesity	2.33e-07	2.55e-06	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—obesity	1.97e-07	2.16e-06	CbGpPWpGaD
